Thermo Fisher Scientific Inc.
TMO · NYSE
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11 | $11 | $10 | $11 |
| % Growth | 2.5% | 4.7% | -9% | – |
| Cost of Goods Sold | $6 | $7 | $6 | $7 |
| Gross Profit | $5 | $4 | $4 | $4 |
| % Margin | 41.8% | 37.3% | 41% | 39.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $2 | $2 | $2 |
| Operating Income | $2 | $2 | $2 | $2 |
| % Margin | 17.5% | 17.7% | 17.8% | 19.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $2 | $2 | $2 | $2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $2 | $2 | $2 | $2 |
| % Margin | 14.5% | 14.9% | 14.5% | 16.1% |
| EPS | 4.28 | 4.28 | 3.99 | 4.79 |
| % Growth | 0% | 7.3% | -16.7% | – |
| EPS Diluted | 4.27 | 4.28 | 3.98 | 4.78 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | $3 | $3 | $3 | $3 |
| % Margin | 25.5% | 25.8% | 25.4% | 26.9% |